Evonik Evonik

X

Find Radio Compass News for Nicardipine

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

left grey arrow
right gray arrow
  • INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML)
  • INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203978

FDA
17 Apr 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218202

FDA
10 Apr 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-27-2024-11790.pdf

FDA
27 Mar 2024

https://www.prnewswire.com/news-releases/senores-pharmaceuticals-inc-announces-the-launch-of-nicardipine-hydrochloride-capsules-usp-20-mg-and-30-mg-in-the-us-market-301937468.html

PR NEWSWIRE
25 Sep 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215377

FDA
17 Jul 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216420

FDA
07 Jul 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217555

FDA
03 May 2023

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-generic-drug/articleshow/96334424.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMIC TIMES
19 Dec 2022

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-generic-drug/articleshow/96334424.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMIC TIMES
19 Dec 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216357

FDA
16 Dec 2022

https://www.biospectrumasia.com/news/25/14696/astellas-transfers-three-products-in-asia-region-to-daiichi-sankyo.html

BIOSPECTRUM ASIA
17 Oct 2019

https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-May-1-2019-1556686753.pdf

FDA
01 May 2019

https://www.raps.org/news-and-articles/news-articles/2018/8/fda-singles-out-three-drug-substances-to-not-be-co?feed=Regulatory-Focus

Zachary Brennan RAPS
27 Aug 2018

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2018-1519803579.pdf

FDA
28 Feb 2018

http://www.fiercepharmamanufacturing.com/story/mylan-recalling-two-injectable-drugs-made-india/2015-03-31

Eric Palmer FIERCE PHARMA MANUFACTURING
31 Mar 2015
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY